Update on Clostridium difficile Infection (CDI)
Einstein/Montefiore Department of Medicine Grand Rounds
Thursday, November 15, 2012
8:00 AM: Forchheimer Medical Science Building 3rd Fl Lecture Hall
Speaker & Info
Dale Gerding, MD
Loyola University Chicago
Stritch School of Medicine
Repeated at 12:15 pm, Cherkasky Auditorium, Montefiore Medical Center
Dr. Darle N. Gerding’s research interests include the epidemiology and prevention of Clostridium difficile disease, antimicrobial resistance, and antimicrobial distribution and kinetics. He has been a Merit Review funded research investigator in the VA for over 35 years and is the author of over 300 peer-reviewed journal publications, book chapters, and review articles. He holds patents for the use of non-toxigenic C. difficile for the prevention and treatment of this disease. He is a member of the editorial boards of Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy, Gut Microbes, and Infection Control and Hospital Epidemiology, and is an ad hoc reviewer for numerous other medical journals.
Dr. Gerding is an infectious diseases specialist and hospital epidemiologist, past president of the Society for Healthcare Epidemiology of America and past chair the antibiotic resistance committee of SHEA. He is a fellow of the Infectious Diseases Society of America and past Chair of the National and Global Public Health Committee and the Antibiotic Resistance Subcommittee of IDSA. He served as a member of the Board of Directors of IDSA from 2005-2008. He is a fellow of the American College of Physicians and a member of the American Society for Microbiology. He is board certified in Internal Medicine and Infectious Diseases.
Dr. Gerding is Professor of Medicine at Loyola University Chicago Stritch School of Medicine in Maywood, Illinois. Prior to his present position, he was Chief of Medicine at VA Chicago, Lakeside Division, and Professor of Medicine at Northwestern University Feinberg School of Medicine.
Objectives - After attending this activity, participants will:
- Review recent epidemiology of CDI in the community and healthcare facilities
- Discuss recent evolution of CDI treatment
- Present data for clinical investigational approaches to CDI management likely to be approved in the next several years
Accreditation: Albert Einstein College of Medicine designates this educational activity for a maximum of 1 credit towards the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the educational activity.
Department of Medicine (Division of Infectious Diseases)